CD274 and hepatocellular carcinoma: In particular, the study performed by Gabrielson and colleagues not only supports the application of the IS as prognostic marker for HCC, but also sheds light on a complex topic that is the rationale of using PD-L1 expression as marker of prognostic significance in HCC.